{{Rsnum
|rsid=10841397
|Chromosome=12
|position=19911034
|Orientation=plus
|GMAF=0.2622
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 17.7 | 48.7 | 33.6
| HCB | 0.7 | 21.9 | 77.4
| JPT | 0.9 | 17.3 | 81.8
| YRI | 8.2 | 27.4 | 64.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.7 | 21.9 | 77.4
| CHD | 0.9 | 17.8 | 81.3
| GIH | 10.9 | 48.5 | 40.6
| LWK | 1.9 | 22.4 | 75.7
| MEX | 3.4 | 31.0 | 65.5
| MKK | 9.5 | 40.1 | 50.3
| TSI | 29.7 | 44.6 | 25.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}